申报总市值
US$35.8亿
申报季度: 2026-03-31 · 持股只数: 90
Vestal Point Capital, LP在最新一期 13F 报告中披露了 90 项持股，申报期为 2026-03-31，总持股市值约为 US$35.8亿，季度换手率为 103.4%。
加仓 RVMD
+705.1% US$2.1亿
减仓 430
-77.8% -US$1.3亿
减仓 ABVX
-21.1% -US$8920.0万
加仓 RGEN
+1014.5% US$9538.3万
减仓 GMED
-52.1% -US$5871.8万
减仓 TYRA
-97.8% -US$6168.5万
| # | 代码 | 标的名称 | 资产子类别 | 占比 | 占比变动 | 持仓量变化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | RVMD | Revolution Medicines INC | 股票-医疗保健 | 6.46% | +5.66% | +705.08% | |
| 2 | BMRN | Biomarin Pharmaceutical INC | 股票-医疗保健 | 5.65% | -0.41% | +19.17% | |
| 3 | ABVX | Abivax Sa-adr | 股票-其他 | 4.67% | -4.04% | -21.05% | |
| 4 | NBIX | Neurocrine Biosciences INC | 股票-医疗保健 | 4.60% | +4.60% | NEW | |
| 5 | ARWR | Arrowhead Pharmaceuticals In | 股票-医疗保健 | 3.99% | +1.96% | +152.78% | |
| 6 | ELVN | Enliven Therapeutics INC | 股票-其他 | 3.56% | +1.55% | -15.14% | |
| 7 | RGEN | Repligen CORP | 股票-医疗保健 | 3.05% | +2.59% | +1014.46% | |
| 8 | BCAX | Bicara Therapeutics INC | 股票-其他 | 3.02% | +0.97% | +51.75% | |
| 9 | NRIX | Nurix Therapeutics INC | 股票-其他 | 2.82% | — | +38.59% | |
| 10 | APGE | Apogee Therapeutics INC | 股票-其他 | 2.59% | +1.18% | +100.00% | |
| 11 | ASND | Ascendis Pharma A/S | 股票-其他 | 2.40% | +1.13% | +114.29% | |
| 12 | IMCR | Immunocore Holdings Plc-adr | 股票-其他 | 2.33% | +1.64% | +372.97% | |
| 13 | TSHA | Taysha Gene Therapies INC | 股票-其他 | 2.25% | — | +30.91% | |
| 14 | DYN | Dyne Therapeutics INC | 股票-其他 | 2.03% | +1.95% | +3233.33% | |
| 15 | SNY | Sanofi-adr | 股票-医疗保健 | 1.89% | +1.89% | NEW | |
| 16 | BCRX | Biocryst Pharmaceuticals INC | 股票-其他 | 1.87% | +1.27% | +212.22% | |
| 17 | SRRK | Scholar Rock Holding CORP | 股票-其他 | 1.82% | +0.77% | +89.20% | |
| 18 | ✓ | Immatics NV | 股票-其他 | 1.70% | — | +0.82% | |
| 19 | BMY | Bristol-myers Squibb Co | 股票-医疗保健 | 1.70% | +1.24% | +300.00% | |
| 20 | ALC | Alcon Inc. | 股票-医疗保健 | 1.69% | -1.27% | -27.60% | |
| 21 | GLUE | Monte Rosa Therapeutics INC | 股票-其他 | 1.66% | +1.25% | +364.96% | |
| 22 | VERA | Vera Therapeutics INC | 股票-其他 | 1.54% | +0.59% | +148.76% | |
| 23 | 430 | Terns Pharmaceuticals INC | 股票-其他 | 1.47% | -4.71% | -77.78% | |
| 24 | GMED | Globus Medical INC - A | 股票-医疗保健 | 1.47% | -2.31% | -52.12% | |
| 25 | BSX | Boston Scientific CORP | 股票-医疗保健 | 1.40% | +1.40% | NEW | |
| 26 | NUVL | Nuvalent Inc-a | 股票-其他 | 1.38% | +1.22% | +947.21% | |
| 27 | COGT | Cogent Biosciences INC | 股票-其他 | 1.32% | +1.32% | NEW | |
| 28 | ANRO | Alto Neuroscience INC | 股票-其他 | 1.30% | — | -16.94% | |
| 29 | RAPP | Rapport Therapeutics INC | 股票-其他 | 1.26% | — | +29.39% | |
| 30 | IRON | Disc Medicine INC | 股票-其他 | 1.25% | — | -4.76% | |
| 31 | UTHR | United Therapeutics CORP | 股票-医疗保健 | 1.24% | +1.24% | NEW | |
| 32 | CLDX | Celldex Therapeutics INC | 股票-其他 | 1.09% | — | +5.08% | |
| 33 | 4XC1 | Kalvista Pharmaceuticals INC | 股票-其他 | 1.04% | — | -2.12% | |
| 34 | XENE | Xenon Pharmaceuticals INC | 股票-其他 | 1.04% | — | +6.65% | |
| 35 | SLDB | Solid Biosciences INC | 股票-其他 | 1.01% | — | -14.02% | |
| 36 | DRUG | Bright Minds Biosciences INC | 股票-其他 | 1.00% | +1.00% | NEW | |
| 37 | PTGX | Protagonist Therapeutics INC | 股票-其他 | 0.96% | +0.96% | NEW | |
| 38 | DNLI | Denali Therapeutics INC | 股票-其他 | 0.95% | +0.69% | +281.36% | |
| 39 | REGN | Regeneron Pharmaceuticals | 股票-医疗保健 | 0.86% | +0.86% | NEW | |
| 40 | WAT | Waters CORP | 股票-医疗保健 | 0.83% | +0.83% | NEW | |
| 41 | VKTX | Viking Therapeutics INC | 股票-医疗保健 | 0.83% | +0.83% | NEW | |
| 42 | INSP | Inspire Medical Systems INC | 股票-医疗保健 | 0.78% | +0.78% | NEW | |
| 43 | ✓ | Crescent Biopharma INC. | 股票-其他 | 0.77% | — | — | |
| 44 | TRVI | Trevi Therapeutics INC | 股票-其他 | 0.72% | +0.72% | NEW | |
| 45 | LXEO | Lexeo Therapeutics INC | 股票-其他 | 0.72% | — | — | |
| 46 | SLNOEUR | Soleno Therapeutics INC | 股票-其他 | 0.68% | +0.68% | NEW | |
| 47 | BBNX | Beta Bionics INC | 股票-其他 | 0.62% | — | +268.59% | |
| 48 | NKTR | Nektar Therapeutics | 股票-其他 | 0.57% | +0.57% | NEW | |
| 49 | CYTK | Cytokinetics INC | 股票-医疗保健 | 0.55% | +0.55% | NEW | |
| 50 | AZN | AstraZeneca PLC | 股票-医疗保健 | 0.55% | +0.55% | NEW |
Q3 2026表现
+19.1%
近4个季度表现
+116%
基于可获取价格的持仓（占申报价值的72%）计算
| 季度 | 持股只数 | 总市值 | 稳定性 | 主要持股 |
|---|---|---|---|---|
| 2026-03-31 | 90 | US$35.8亿 | 100 | |
| 2025-12-31 | 76 | US$29.4亿 | 100 | |
| 2025-09-30 | 81 | US$22.1亿 | 96 | |
| 2025-06-30 | 72 | US$19.0亿 | 0 | |
| 2025-03-31 | 63 | US$14.0亿 | 0 | |
| 2024-12-31 | 73 | US$16.9亿 | 0 | |
| 2024-09-30 | 69 | US$13.2亿 | 0 | |
| 2024-06-30 | 60 | US$13.4亿 | 0 | |
| 2024-03-31 | 58 | US$12.1亿 | 0 | |
| 2023-12-31 | 48 | US$9.4亿 | 0 |
Vestal Point Capital, LP 在 2026-03-31 最显著的持仓异动： 清仓: Invesco Qqq Trust Series 1 (QQQ); 清仓: Arcellx INC (ACLXGBX); 新建仓: Neurocrine Biosciences INC (NBIX); 清仓: Dexcom INC (DXCM); 清仓: Merck & Co. INC. (MRK).